In early-stage trials called dose escalation studies, drug developers usually want to test progressively higher doses of their therapies.
Not Perspective Therapeutics. The radiopharma biotech …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The spring IPO class is here. Boundless Bio, a cancer biotech with two different oral small molecules in Phase 1 testing, eyes about $88.4 million
Children and adolescents diagnosed with high blood pressure have double the risk of major cardiovascular problems as adults, a new study that followed them into
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS